543
Participants
Start Date
May 8, 2019
Primary Completion Date
October 20, 2023
Study Completion Date
October 20, 2023
Sacituzumab Govitecan-hziy
Administered intravenously
Eribulin
Administered intravenously per NCCN guidelines
Capecitabine
Administered orally per NCCN guidelines
Gemcitabine
Administered intravenously per NCCN guidelines
Vinorelbine
Administered intravenously per NCCN guidelines
Antoni van Leeuwenhoekziekenhuis, Amsterdam
Maastricht UMC+, Maastricht
Laura and Isaac Perlmutter Cancer Center/NYU Langone Health, New York
Icahn School of Medicine at Mount Sinai, New York
Columbia University Medical Center, New York
Memorial Sloan Kettering Cancer Center, New York
Hospital Provincial de Castellón, Castillón
New York Oncology Hematology, P.C., Albany
HELIOS Klinikum Berlin-Buch, Berlin
Complejo Hospitalario Universitario A Coruna, A Coruña
Magee-Womens Hospital of UPMC, Pittsburgh
Hospital Clinico Universitario de Santiago de Compostela, Santiago de Compostela
Thomas Jefferson University, Philadelphia
Georgetown University Medical Center, Washington D.C.
Ospedale San Raffaele, Milan
Onkologische Schwerpunktpraxis Eppendorf, Hamburg
Ospedale di Desio, Desio
Maryland Oncology Hematology, P.A., Rockville
Centre Georges-Francois Leclerc, Dijon
Mercy Medical Center, Medical Oncology & Hematology, Baltimore
Virginia Cancer Specialists, Arlington
Virginia Oncology Associates, Norfolk
Oncology & Hematology Associates of Southwest Virginia, Inc. DBA Blue Ridge Cancer Care, Salem
Hôpital Jean-Minjoz, Besançon
Hospital Universitari Arnau de Vilanova, Lleida
Hospital General Universitario Gregorio Maranon, Madrid
Instituto Oncologico Bureau (IOB), Madrid
Hospital Universitario 12 de Octubre, Madrid
Azienda Unità Sanitaria Locale di Piacenza-Ospedale Guglielmo da Saliceto, Piacenza
Gynakologisch-Onkologische Praxis Hannover, Hanover
Emory University - Winship Cancer Institute, Atlanta
Northside Hospital, Inc., Atlanta
Institut Claudius Regaud, Toulouse
Orlando Health, Inc., Orlando
University of Miami - Sylvester Comprehensive Cancer Center, Miami
Miami Cancer Institute, Miami
Moffitt Cancer Center, Tampa
Institut Régional du Cancer de Montpellier, Montpellier
Tennessee Oncology, PLLC, Nashville
Vanderbilt University Medical Center, Nashville
The West Clinic, PC dba West Cancer Center, Germantown
James Graham Brown Cancer Center, Louisville
Hospital Universitario Virgen del Rocio, Seville
Institut de Cancérologie Lucien Neuwirth, Saint-Priest-en-Jarez
The Ohio State University, Columbus
Kliniken Essen-Mitte, Essen
Marienhospital Bottrop, Bottrop
Gynakologisches Zentrum Bonn, Bonn
Allina Health, Virginia Piper Cancer Institute, Minneapolis
Masonic Cancer Center, University of Minnesota, Minneapolis
Praxisklinik für Hämatologie und Onkologie Koblenz, Koblenz
Hopital de Mercy, Ars-Laquenexy
St. Vincent Frontier Cancer Center, Billings
Centrum für Hämatologie und Onkologie Bethanien, Frankfurt
University of Chicago Medical Center, Chicago
Washington University School of Medicine - Siteman Cancer Center, St Louis
Saint Luke's Cancer Institute, Kansas City
The University of Kansas Cancer Center, Westwood
Universitätsmedizin Mannheim, Mannheim
Centre Leon Berard, Lyon
Nationales Centrum für Tumorerkrankungen - Heidelberg, Heidelberg
Hospices Civils de Lyon, Pierre-Bénite
Highlands Oncology Group, Fayetteville
Institut Curie, Paris
Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas
University of Texas Southwestern Harold C. Simmons Comprehensive Cancer Center, Dallas
Texas Oncology-Longview Cancer Center, Longview
Texas Oncology-Denton South, Denton
Houston Methodist Hospital/Houston Methodist Cancer Center, Houston
UT Health San Antonio - Mays Cancer Center, San Antonio
Rocky Mountain Cancer Centers, Aurora
University of Colorado, Aurora
Institut Sainte Catherine, Avignon
HonorHealth Research Institute, Avondale
Arizona Oncology Associates, PC, Tucson
Los Angeles Hematology Oncology Medical Group, Los Angeles
UCLA Department of Medicine - Hematology/Oncology, Los Angeles
Universitätsklinikum Erlangen, Erlangen
University of California, San Diego Moores Cancer Center, La Jolla
Southern California Permanente Medical Group, San Diego
University of California, Irvine Medical Center-Chao Family Comprehensive Cancer Center, Orange
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
Northwest Medical Specialties, PLLC, Tacoma
Yale University Cancer Center, New Haven
Massachusetts General Hospital, Boston
Beth Israel Deaconess Medical Center, Boston
Dana Farber Cancer Institute, Boston
Summit Medical Group, Florham Park
Rutgers Cancer Institute of New Jersey, New Brunswick
Chirec Cancer Institute, Brussels
Institut Jules Bordet, Brussels
Universitair Ziekenhuis Leuven, Leuven
CHU UCL Namur/Site Sainte Elisabeth, Namur
Centre Hospitalier de L'Universite de Montreal - Hôpital Notre-Dame, Montreal
Centre Hospitalier Universitaire de Sherbrooke - Fleurimont, Sherbrooke
DIAKOVERE Krankenhaus gGmbH Henriettenstift - Standort Kirchrode, Hanover
Klinikum Mutterhaus der Borromäerinnen, Trier
Azienda Ospedaliera Spedali Civili di Brescia, Brescia
Ospedale Vito Fazzi di Lecce, Lecce
Azienda Ospedaliera San Gerardo di Monza, Monza
Medisch Centrum Haaglanden Antoniushove, Leidschendam
Royal Cornwall Hospital NHS Trust, Cornwell
The Christie NHS Foundation Trust, Manchester
Nova Scotia Cancer Centre, Halifax
Städtisches Klinikum Dessau, Dessau
IFO Istituto Nazionale dei Tumori Regina Elena, Rome
Hospital Quirónsalud Barcelona Instituto Oncologico Baselga, Barcelona
Hospital Universitari Vall d'Hebron, Barcelona
Hospital de la Santa Creu I Sant Pau, Barcelona
Royal Surrey County Hospital, Guildford
Leicester Royal Infirmary, Leicester
Barts Health NHS Trust, London
The Royal Marsden NHS Foundation Trust, London
Lead Sponsor
Gilead Sciences
INDUSTRY